Your browser doesn't support javascript.
loading
Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.
Zhu, Tianhui; Okabe, Atsushi; Usui, Genki; Fujiki, Ryoji; Komiyama, Daichi; Huang, Kie Kyon; Seki, Motoaki; Fukuyo, Masaki; Abe, Hiroyuki; Ning, Meng; Okada, Tomoka; Minami, Mizuki; Matsumoto, Makoto; Fan, Qin; Rahmutulla, Bahityar; Hoshii, Takayuki; Tan, Patrick; Morikawa, Teppei; Ushiku, Tetsuo; Kaneda, Atsushi.
Afiliação
  • Zhu T; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Okabe A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Usui G; Health and Disease Omics Center, Chiba University, Chiba 260-8670, Japan.
  • Fujiki R; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Komiyama D; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Huang KK; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Seki M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Fukuyo M; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.
  • Abe H; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ning M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Okada T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Minami M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Matsumoto M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Fan Q; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Rahmutulla B; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Hoshii T; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Tan P; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Morikawa T; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ushiku T; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.
  • Kaneda A; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138632, Singapore.
NAR Cancer ; 6(2): zcae020, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38720882
ABSTRACT
Enhancer cis-regulatory elements play critical roles in gene regulation at many stages of cell growth. Enhancers in cancer cells also regulate the transcription of oncogenes. In this study, we performed a comprehensive analysis of long-range chromatin interactions, histone modifications, chromatin accessibility and expression in two gastric cancer (GC) cell lines compared to normal gastric epithelial cells. We found that GC-specific enhancers marked by histone modifications can activate a population of genes, including some oncogenes, by interacting with their proximal promoters. In addition, motif analysis of enhancer-promoter interacting enhancers showed that GC-specific transcription factors are enriched. Among them, we found that MYB is crucial for GC cell growth and activated by the enhancer with an enhancer-promoter loop and TCF7 upregulation. Clinical GC samples showed epigenetic activation of enhancers at the MYB locus and significant upregulation of TCF7 and MYB, regardless of molecular GC subtype and clinicopathological factors. Single-cell RNA sequencing of gastric mucosa with intestinal metaplasia showed high expression of TCF7 and MYB in intestinal stem cells. When we inactivated the loop-forming enhancer at the MYB locus using CRISPR interference (dCas9-KRAB), GC cell growth was significantly inhibited. In conclusion, we identified MYB as an oncogene activated by a loop-forming enhancer and contributing to GC cell growth.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article